Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|October 3, 2018
Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B VirusTim R Cressey, Linda Harrison, Jullapong Achalapong, et al.
The Journal of Infectious Diseases|September 22, 2017
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials ParticipantsKatie R Mollan, Camlin Tierney, Jacklyn N Hellwege, et al.
Annals of Internal Medicine|February 16, 2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1Eric S Daar, Camlin Tierney, Margaret A Fischl, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Plos One|August 20, 2021
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trialLynda Stranix-Chibanda, Camlin Tierney, Mauricio Pinilla, et al.
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
The Pediatric Infectious Disease Journal|January 19, 2021
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092Maxensia Owor, Camlin Tierney, Lauren Ziemba, et al.
The New England Journal of Medicine|December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapyPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B VirusNicolas Salvadori, Bo Fan, Waralee Teeyasoontranon, et al.
Plos One|February 5, 2021
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trialLynda Stranix-Chibanda, Camlin Tierney, Dorothy Sebikari, et al.
Pageof 7